abstract |
transglutaminase 2 (tg2) inhibitors. The present invention relates to compounds and pharmaceutical compositions containing such compounds which inhibit transglutaminase 2 (tg2). also described herein are methods of using such tg2 inhibitors, alone or in combination with other compounds, to treat diseases or conditions that would benefit from inhibition of tg2. |